Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why WuXi PharmaTech's Earnings May Be Less Than Awesome
Motley Fool
Thursday, September 27, 2012 - 6:53pm
tags:
earnings, WuXi PharmaTech
10 Reasons To Buy Ampio Pharmaceuticals
Seeking Alpha
Thursday, September 27, 2012 - 6:50pm
tags:
Ampio Pharmaceuticals
Science advisors lay out ambitious plan to double FDA approval rates
Fierce Biotech
Thursday, September 27, 2012 - 11:37am
tags:
FDA, drug approvals
Pfizer, Merck Ink Deals In China To Make Up For Shrinking Revenue
Seeking Alpha
Thursday, September 27, 2012 - 11:34am
tags:
Pfizer, Merck, China, GSK, JNJ, Zhejiang Hisun Pharma, Novartis
Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment
Bloomberg
Thursday, September 27, 2012 - 11:26am
tags:
colorectal cancer, Bayer, ONYX Pharmaceuticals, FDA, regorafenib
Depomed sues FDA over 'additional hurdles' to orphan exclusivity
Fierce Pharma
Thursday, September 27, 2012 - 11:24am
tags:
FDA, Depomed, Gralise
As AstraZeneca's new CEO prepares to step in, calls for M&A intensify
Fierce Pharma
Thursday, September 27, 2012 - 11:24am
tags:
AstraZeneca, M&A, Pascal Soriot
ACLU Asks Supreme Court To Review Gene Patents
Pharmalot
Thursday, September 27, 2012 - 11:22am
tags:
genes, patents, Mylan, ACLU
Reckitt's Decision Opens The Door For Titan Pharma And BioDelivery Sciences
Seeking Alpha
Thursday, September 27, 2012 - 11:14am
tags:
BioDelivery Sciences, Reckitt Benckiser, Titan Pharmaceuticals, Suboxone, opioid addiction
Forest Labs files for approval of depression drug
Yahoo/AP
Thursday, September 27, 2012 - 11:12am
tags:
antidepressants, Forest Labs, levomilnacipran
Hemispherx's Ampligen Rehash Unlikely to Impress FDA
TheStreet.com
Thursday, September 27, 2012 - 10:53am
tags:
Hemispherx, Ampligen, FDA, chronic fatigue syndrome
Achillion Announces Positive Proof-of-Concept Data With ACH-3102
Yahoo
Thursday, September 27, 2012 - 10:51am
tags:
ACH-3102, Achillion
Amarin: A Good Entry Point Ahead Of Major News Next Month
Seeking Alpha
Thursday, September 27, 2012 - 10:39am
tags:
Amarin, Vascepa
Glaxo Case Pushes U.S. Health Settlements to $6.6 Billion
Bloomberg
Thursday, September 27, 2012 - 10:36am
tags:
GSK, settlements, Paxil, Wellbutrin
2 Shrinking Biotech Companies
Motley Fool
Thursday, September 27, 2012 - 10:29am
tags:
Sanofi, Dendreon
A.P. Pharma: New Board Member Brings Great Expertise To Possible Launch Of APF530
Seeking Alpha
Thursday, September 27, 2012 - 10:29am
tags:
AP Pharma, Sanofi, APF530
Protalix receives marketing authorization for Elelyso from Israel
Yahoo/Fly on the Wall
Thursday, September 27, 2012 - 10:27am
tags:
Protalix, Elelyso, Israel, Gaucher disease
FDA to decide by March on Pfizer/Bristol blood thinner
Reuters
Wednesday, September 26, 2012 - 10:04pm
tags:
FDA, Pfizer, Bristol-Myers Squibb, bloodthinners, Eliquis
Merck Returns To Cardiome All Rights To Atrial Fibrillation Drug Vernakalant
Forbes
Wednesday, September 26, 2012 - 10:02pm
tags:
Merck, Cardiome, Vernakalant, atrial fibrillation
PsiOxus Starts Human Tests of Cancer Vaccine
Bloomberg
Wednesday, September 26, 2012 - 12:21pm
tags:
PsiOxus, vaccines, GSK, cancer, ColoAd1

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.